[Changes in blood coagulation in diabetic nephropathy].

Area of Science:

• Internal Medicine
• Hematology
• Nephrology

Context:

• Diabetes mellitus is a complex metabolic disorder associated with microvascular and macrovascular complications.
• Diabetic nephropathy, a significant complication, affects kidney function and is linked to increased cardiovascular risk.
• Hemocoagulation plays a critical role in the pathogenesis of thrombotic events, especially in patients with diabetes.

Purpose:

• To investigate hemocoagulation indices in diabetic patients, with a specific focus on those with diabetic nephropathy.
• To identify specific coagulation parameters that are altered in the presence and severity of diabetic nephropathy.
• To explore the potential link between observed coagulation changes and underlying atherosclerosis in diabetic patients.

Summary:

• A study involving 52 diabetics, 32 with diabetic nephropathy, analyzed thrombocyte count, adhesion, aggregation, various clotting times (recalcification, heparin-recalcification, partial thromboplastin time, prothrombin time), coagulation retraction, and thrombelastography.
• Results indicated increased blood coagulation in diabetics, significantly more pronounced in those with diabetic nephropathy.
• Thrombocyte adhesion, partial thromboplastin time, and recalcification/heparin-recalcification times showed the most significant alterations, with more advanced nephropathy correlating with more pronounced hypercoagulability.

Impact:

• The findings suggest that hypercoagulability in diabetic nephropathy is not solely diabetes-specific but likely associated with comorbid atherosclerosis.
• These alterations in hemocoagulation may necessitate the consideration of anticoagulant and antiplatelet agents in the management of diabetic nephropathy patients.
• This research highlights the importance of assessing coagulation status in diabetic nephropathy for risk stratification and therapeutic intervention.